课题基金 / 基金详情

Development of in vitro model of bone destruction by cultured rheumatoid synovium and its inhibition

Development of in vitro model of bone destruction by cultured rheumatoid synovium and its inhibition
类风湿滑膜培养骨破坏体外模型的建立及其抑制
批准号:
10670437
负责人:
SUZUKI Yasuo
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SUZUKI Yasuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Osteoclasts, bone resorbing cells in human tissues, may be involved in the process of rheumatoid bone destruction. To test this hypothesis, we developed an in vitro model of bone destruction by osteoclast-like cells derived from cultured rheumatoid synovial tissue without using any inducers. When a piece of rheumatoid synovial tissue was cultured on the plate, fibroblast- and macrophage-like cells came out from the tissue and proliferated in the coexistence of lymphocytes. After 14 days of culture, multinucleated cells with tartrate-resistant acid phosphatase activity appeared. These cells expressed vacuolar HィイD1+ィエD1-ATPase, the vitronectin receptor, and cathepsin K. Although [ィイD1125|ィエD1]-salmon calcitonin binding was very low, the cells contained ringed structures of F-actin and showed strong bone resorbing activity on ivory slices. Proliferation of macrophage-like cells and formation of multinucleated cells continued during 6 months of culture in the presence of fibroblast-like cells. The bone-resorbing activity of multinucleated cells derived from rheumatoid synovial tissue was much higher than that of cells from osteoarthritis synovial tissue, and was related to the disease activity of rheumatoid arthritis. Our culture system reproduced in vitro the process of bone destruction by rheumatoid synovium, including the proliferation and fusion of precursor cells, polarization, activation, and bone tissue resorption. This system may provide a tool for understanding the mechanisms of bone destruction in rheumatoid arthritis and for the development of new therapies to prevent bone destruction.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
鈴木康夫: "二次性骨粗鬆症"Clinical Calcium. 9. 163-165 (1999)
Yasuo Suzuki:“继发性骨质疏松症”临床钙。9. 163-165 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田島千秋,鈴木康夫: "最新内科学大系特別巻2 内科リファレンスブック 疾患編1 自己免疫疾患(総論)と免疫不全(分担執筆)" 中山書店, 369-382(14) (1998)
田岛千明、铃木康夫:“最新内科专卷2内科参考书疾病版1自身免疫性疾病(概述)和免疫缺陷(合着)”中山书店,369-382(14)(1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Suzuki Y. et al.: "Elevation of serum hepatic transaminotrasferases during treatment of rheumatoid arthritis with low-dose methotrxate : Risk factors and response to folic acid"Scand J Rheumatol. 28. 1-9 (1999)
Suzuki Y.等人:“用低剂量甲氨蝶呤治疗类风湿关节炎期间血清肝转氨酶升高:危险因素和对叶酸的反应”Scand J Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Suzuki Y,et al: "Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate:Risk factors and response to folic Acid" Scand J Rheumatol. in press.
Suzuki Y 等人:“低剂量甲氨蝶呤治疗类风湿性关节炎期间血清肝转氨酶升高:危险因素和对叶酸的反应”Scand J Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Investigation of serum Vitamin D levels and first immunoglobulin reactivity in Kawasaki disease patients
    • 批准号:
      16K19647
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.41万
    • 财政年份:
      2016
    • 负责人:
      SUZUKI Yasuo
    • 依托单位:
    Development of a device for the surveillance of the mutated highly pathogenic influenza viruses which acquired human-type receptor binding specificity
    • 批准号:
      25670219
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      SUZUKI Yasuo
    • 依托单位:
    Adaptive resource allocation based on multiple dimensional radio resources by cognitive radio techniques
    Contact Force Distribution of High Strength Bolted Tensile Joints with Deformable Filler Plate
    • 批准号:
      20760297
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2008
    • 负责人:
      SUZUKI Yasuo
    • 依托单位:
    海外基金